Global Radiopharmaceuticals for Diagnosis Market Growth 2026-2032
The global Radiopharmaceuticals for Diagnosis market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Diagnostic radiopharmaceuticals are a special class of drugs used in medical imaging diagnosis. These drugs contain radioactive isotopes that can locate and emit radiation signals in specific organs or tissues in the body. Through these signals, doctors can use nuclear medicine imaging equipment (such as single photon emission computed tomography (SPECT) and positron emission tomography (PET)) to detect and evaluate the presence and extent of various diseases, such as cancer, heart disease, thyroid dysfunction, brain disease, etc.
United States market for Radiopharmaceuticals for Diagnosis is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Radiopharmaceuticals for Diagnosis is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Radiopharmaceuticals for Diagnosis is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Radiopharmaceuticals for Diagnosis players cover Atom High-tech Co., Ltd., Shanghai Xinke Pharmaceutical Co., Ltd., Guangdong Xi'ai Pharmaceutical Co., Ltd., Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory, Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Radiopharmaceuticals for Diagnosis Industry Forecast? looks at past sales and reviews total world Radiopharmaceuticals for Diagnosis sales in 2025, providing a comprehensive analysis by region and market sector of projected Radiopharmaceuticals for Diagnosis sales for 2026 through 2032. With Radiopharmaceuticals for Diagnosis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radiopharmaceuticals for Diagnosis industry.
This Insight Report provides a comprehensive analysis of the global Radiopharmaceuticals for Diagnosis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Radiopharmaceuticals for Diagnosis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Radiopharmaceuticals for Diagnosis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radiopharmaceuticals for Diagnosis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radiopharmaceuticals for Diagnosis.
This report presents a comprehensive overview, market shares, and growth opportunities of Radiopharmaceuticals for Diagnosis market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Radiopharmaceuticals for Diagnosis market?
What factors are driving Radiopharmaceuticals for Diagnosis market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Radiopharmaceuticals for Diagnosis market opportunities vary by end market size?
How does Radiopharmaceuticals for Diagnosis break out by Type, by Application?
Diagnostic radiopharmaceuticals are a special class of drugs used in medical imaging diagnosis. These drugs contain radioactive isotopes that can locate and emit radiation signals in specific organs or tissues in the body. Through these signals, doctors can use nuclear medicine imaging equipment (such as single photon emission computed tomography (SPECT) and positron emission tomography (PET)) to detect and evaluate the presence and extent of various diseases, such as cancer, heart disease, thyroid dysfunction, brain disease, etc.
United States market for Radiopharmaceuticals for Diagnosis is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Radiopharmaceuticals for Diagnosis is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Radiopharmaceuticals for Diagnosis is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Radiopharmaceuticals for Diagnosis players cover Atom High-tech Co., Ltd., Shanghai Xinke Pharmaceutical Co., Ltd., Guangdong Xi'ai Pharmaceutical Co., Ltd., Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory, Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Radiopharmaceuticals for Diagnosis Industry Forecast? looks at past sales and reviews total world Radiopharmaceuticals for Diagnosis sales in 2025, providing a comprehensive analysis by region and market sector of projected Radiopharmaceuticals for Diagnosis sales for 2026 through 2032. With Radiopharmaceuticals for Diagnosis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radiopharmaceuticals for Diagnosis industry.
This Insight Report provides a comprehensive analysis of the global Radiopharmaceuticals for Diagnosis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Radiopharmaceuticals for Diagnosis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Radiopharmaceuticals for Diagnosis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radiopharmaceuticals for Diagnosis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radiopharmaceuticals for Diagnosis.
This report presents a comprehensive overview, market shares, and growth opportunities of Radiopharmaceuticals for Diagnosis market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Technetium [99mTc] Dithiodithiocarbamate
- Technetium [99mTc] Polymerized Albumin
- Technetium [99mTc] Pentetate
- Strontium [89Sr] Chloride
- Iodine [125I] Sealed Seed Source
- Sodium Iodide [131I]
- Other
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Atom High-tech Co., Ltd.
- Shanghai Xinke Pharmaceutical Co., Ltd.
- Guangdong Xi'ai Pharmaceutical Co., Ltd.
- Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory
- Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd.
- Chengdu Yunke Pharmaceutical Co., Ltd.
- Shanghai Atom Kexing Pharmaceutical Co., Ltd.
- Shenzhen Larven Bioengineering Technology Co., Ltd.
- Ningbo Jun'an Pharmaceutical Technology Co., Ltd.
- Beijing Zhibo High-tech Biotechnology Co., Ltd.
- Tianjin Said Biopharmaceutical Co., Ltd.
- Chengdu Zhonghe Gaotong Isotope Co., Ltd.
- Chengdu Xinke Pharmaceutical Co., Ltd.
- Jubilant Radiopharma
- PDRadiopharma Inc.
- GE Healthcare Ltd
- DOE IP
- RadioMedix, Inc.
- Lantheus
What is the 10-year outlook for the global Radiopharmaceuticals for Diagnosis market?
What factors are driving Radiopharmaceuticals for Diagnosis market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Radiopharmaceuticals for Diagnosis market opportunities vary by end market size?
How does Radiopharmaceuticals for Diagnosis break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Radiopharmaceuticals for Diagnosis Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Radiopharmaceuticals for Diagnosis by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Radiopharmaceuticals for Diagnosis by Country/Region, 2021, 2025 & 2032
2.2 Radiopharmaceuticals for Diagnosis Segment by Type
2.2.1 Technetium 99mTc Dithiodithiocarbamate
2.2.2 Technetium 99mTc Polymerized Albumin
2.2.3 Technetium 99mTc Pentetate
2.2.4 Strontium 89Sr Chloride
2.2.5 Iodine 125I Sealed Seed Source
2.2.6 Sodium Iodide 131I
2.2.7 Other
2.2.8 Radiopharmaceuticals for Diagnosis Sales by Type
2.2.8.1 Global Radiopharmaceuticals for Diagnosis Sales Market Share by Type (2021-2026)
2.2.8.2 Global Radiopharmaceuticals for Diagnosis Revenue and Market Share by Type (2021-2026)
2.2.8.3 Global Radiopharmaceuticals for Diagnosis Sale Price by Type (2021-2026)
2.3 Radiopharmaceuticals for Diagnosis Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 Radiopharmaceuticals for Diagnosis Sales by Application
2.3.4.1 Global Radiopharmaceuticals for Diagnosis Sale Market Share by Application (2021-2026)
2.3.4.2 Global Radiopharmaceuticals for Diagnosis Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Radiopharmaceuticals for Diagnosis Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Radiopharmaceuticals for Diagnosis Breakdown Data by Company
3.1.1 Global Radiopharmaceuticals for Diagnosis Annual Sales by Company (2021-2026)
3.1.2 Global Radiopharmaceuticals for Diagnosis Sales Market Share by Company (2021-2026)
3.2 Global Radiopharmaceuticals for Diagnosis Annual Revenue by Company (2021-2026)
3.2.1 Global Radiopharmaceuticals for Diagnosis Revenue by Company (2021-2026)
3.2.2 Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Company (2021-2026)
3.3 Global Radiopharmaceuticals for Diagnosis Sale Price by Company
3.4 Key Manufacturers Radiopharmaceuticals for Diagnosis Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Radiopharmaceuticals for Diagnosis Product Location Distribution
3.4.2 Players Radiopharmaceuticals for Diagnosis Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR RADIOPHARMACEUTICALS FOR DIAGNOSIS BY GEOGRAPHIC REGION
4.1 World Historic Radiopharmaceuticals for Diagnosis Market Size by Geographic Region (2021-2026)
4.1.1 Global Radiopharmaceuticals for Diagnosis Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Radiopharmaceuticals for Diagnosis Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Radiopharmaceuticals for Diagnosis Market Size by Country/Region (2021-2026)
4.2.1 Global Radiopharmaceuticals for Diagnosis Annual Sales by Country/Region (2021-2026)
4.2.2 Global Radiopharmaceuticals for Diagnosis Annual Revenue by Country/Region (2021-2026)
4.3 Americas Radiopharmaceuticals for Diagnosis Sales Growth
4.4 APAC Radiopharmaceuticals for Diagnosis Sales Growth
4.5 Europe Radiopharmaceuticals for Diagnosis Sales Growth
4.6 Middle East & Africa Radiopharmaceuticals for Diagnosis Sales Growth
5 AMERICAS
5.1 Americas Radiopharmaceuticals for Diagnosis Sales by Country
5.1.1 Americas Radiopharmaceuticals for Diagnosis Sales by Country (2021-2026)
5.1.2 Americas Radiopharmaceuticals for Diagnosis Revenue by Country (2021-2026)
5.2 Americas Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026)
5.3 Americas Radiopharmaceuticals for Diagnosis Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Radiopharmaceuticals for Diagnosis Sales by Region
6.1.1 APAC Radiopharmaceuticals for Diagnosis Sales by Region (2021-2026)
6.1.2 APAC Radiopharmaceuticals for Diagnosis Revenue by Region (2021-2026)
6.2 APAC Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026)
6.3 APAC Radiopharmaceuticals for Diagnosis Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Radiopharmaceuticals for Diagnosis by Country
7.1.1 Europe Radiopharmaceuticals for Diagnosis Sales by Country (2021-2026)
7.1.2 Europe Radiopharmaceuticals for Diagnosis Revenue by Country (2021-2026)
7.2 Europe Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026)
7.3 Europe Radiopharmaceuticals for Diagnosis Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Radiopharmaceuticals for Diagnosis by Country
8.1.1 Middle East & Africa Radiopharmaceuticals for Diagnosis Sales by Country (2021-2026)
8.1.2 Middle East & Africa Radiopharmaceuticals for Diagnosis Revenue by Country (2021-2026)
8.2 Middle East & Africa Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026)
8.3 Middle East & Africa Radiopharmaceuticals for Diagnosis Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Radiopharmaceuticals for Diagnosis
10.3 Manufacturing Process Analysis of Radiopharmaceuticals for Diagnosis
10.4 Industry Chain Structure of Radiopharmaceuticals for Diagnosis
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Radiopharmaceuticals for Diagnosis Distributors
11.3 Radiopharmaceuticals for Diagnosis Customer
12 WORLD FORECAST REVIEW FOR RADIOPHARMACEUTICALS FOR DIAGNOSIS BY GEOGRAPHIC REGION
12.1 Global Radiopharmaceuticals for Diagnosis Market Size Forecast by Region
12.1.1 Global Radiopharmaceuticals for Diagnosis Forecast by Region (2027-2032)
12.1.2 Global Radiopharmaceuticals for Diagnosis Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Radiopharmaceuticals for Diagnosis Forecast by Type (2027-2032)
12.7 Global Radiopharmaceuticals for Diagnosis Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Atom High-tech Co., Ltd.
13.1.1 Atom High-tech Co., Ltd. Company Information
13.1.2 Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.1.3 Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Atom High-tech Co., Ltd. Main Business Overview
13.1.5 Atom High-tech Co., Ltd. Latest Developments
13.2 Shanghai Xinke Pharmaceutical Co., Ltd.
13.2.1 Shanghai Xinke Pharmaceutical Co., Ltd. Company Information
13.2.2 Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.2.3 Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Shanghai Xinke Pharmaceutical Co., Ltd. Main Business Overview
13.2.5 Shanghai Xinke Pharmaceutical Co., Ltd. Latest Developments
13.3 Guangdong Xi'ai Pharmaceutical Co., Ltd.
13.3.1 Guangdong Xi'ai Pharmaceutical Co., Ltd. Company Information
13.3.2 Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.3.3 Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Guangdong Xi'ai Pharmaceutical Co., Ltd. Main Business Overview
13.3.5 Guangdong Xi'ai Pharmaceutical Co., Ltd. Latest Developments
13.4 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory
13.4.1 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Company Information
13.4.2 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.4.3 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Main Business Overview
13.4.5 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Latest Developments
13.5 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd.
13.5.1 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Company Information
13.5.2 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.5.3 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Main Business Overview
13.5.5 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Latest Developments
13.6 Chengdu Yunke Pharmaceutical Co., Ltd.
13.6.1 Chengdu Yunke Pharmaceutical Co., Ltd. Company Information
13.6.2 Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.6.3 Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Chengdu Yunke Pharmaceutical Co., Ltd. Main Business Overview
13.6.5 Chengdu Yunke Pharmaceutical Co., Ltd. Latest Developments
13.7 Shanghai Atom Kexing Pharmaceutical Co., Ltd.
13.7.1 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Company Information
13.7.2 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.7.3 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Main Business Overview
13.7.5 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Latest Developments
13.8 Shenzhen Larven Bioengineering Technology Co., Ltd.
13.8.1 Shenzhen Larven Bioengineering Technology Co., Ltd. Company Information
13.8.2 Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.8.3 Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Shenzhen Larven Bioengineering Technology Co., Ltd. Main Business Overview
13.8.5 Shenzhen Larven Bioengineering Technology Co., Ltd. Latest Developments
13.9 Ningbo Jun'an Pharmaceutical Technology Co., Ltd.
13.9.1 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Company Information
13.9.2 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.9.3 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Main Business Overview
13.9.5 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Latest Developments
13.10 Beijing Zhibo High-tech Biotechnology Co., Ltd.
13.10.1 Beijing Zhibo High-tech Biotechnology Co., Ltd. Company Information
13.10.2 Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.10.3 Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Beijing Zhibo High-tech Biotechnology Co., Ltd. Main Business Overview
13.10.5 Beijing Zhibo High-tech Biotechnology Co., Ltd. Latest Developments
13.11 Tianjin Said Biopharmaceutical Co., Ltd.
13.11.1 Tianjin Said Biopharmaceutical Co., Ltd. Company Information
13.11.2 Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.11.3 Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Tianjin Said Biopharmaceutical Co., Ltd. Main Business Overview
13.11.5 Tianjin Said Biopharmaceutical Co., Ltd. Latest Developments
13.12 Chengdu Zhonghe Gaotong Isotope Co., Ltd.
13.12.1 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Company Information
13.12.2 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.12.3 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Main Business Overview
13.12.5 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Latest Developments
13.13 Chengdu Xinke Pharmaceutical Co., Ltd.
13.13.1 Chengdu Xinke Pharmaceutical Co., Ltd. Company Information
13.13.2 Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.13.3 Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Chengdu Xinke Pharmaceutical Co., Ltd. Main Business Overview
13.13.5 Chengdu Xinke Pharmaceutical Co., Ltd. Latest Developments
13.14 Jubilant Radiopharma
13.14.1 Jubilant Radiopharma Company Information
13.14.2 Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.14.3 Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Jubilant Radiopharma Main Business Overview
13.14.5 Jubilant Radiopharma Latest Developments
13.15 PDRadiopharma Inc.
13.15.1 PDRadiopharma Inc. Company Information
13.15.2 PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.15.3 PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 PDRadiopharma Inc. Main Business Overview
13.15.5 PDRadiopharma Inc. Latest Developments
13.16 GE Healthcare Ltd
13.16.1 GE Healthcare Ltd Company Information
13.16.2 GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.16.3 GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 GE Healthcare Ltd Main Business Overview
13.16.5 GE Healthcare Ltd Latest Developments
13.17 DOE IP
13.17.1 DOE IP Company Information
13.17.2 DOE IP Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.17.3 DOE IP Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 DOE IP Main Business Overview
13.17.5 DOE IP Latest Developments
13.18 RadioMedix, Inc.
13.18.1 RadioMedix, Inc. Company Information
13.18.2 RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.18.3 RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 RadioMedix, Inc. Main Business Overview
13.18.5 RadioMedix, Inc. Latest Developments
13.19 Lantheus
13.19.1 Lantheus Company Information
13.19.2 Lantheus Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.19.3 Lantheus Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Lantheus Main Business Overview
13.19.5 Lantheus Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Radiopharmaceuticals for Diagnosis Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Radiopharmaceuticals for Diagnosis by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Radiopharmaceuticals for Diagnosis by Country/Region, 2021, 2025 & 2032
2.2 Radiopharmaceuticals for Diagnosis Segment by Type
2.2.1 Technetium 99mTc Dithiodithiocarbamate
2.2.2 Technetium 99mTc Polymerized Albumin
2.2.3 Technetium 99mTc Pentetate
2.2.4 Strontium 89Sr Chloride
2.2.5 Iodine 125I Sealed Seed Source
2.2.6 Sodium Iodide 131I
2.2.7 Other
2.2.8 Radiopharmaceuticals for Diagnosis Sales by Type
2.2.8.1 Global Radiopharmaceuticals for Diagnosis Sales Market Share by Type (2021-2026)
2.2.8.2 Global Radiopharmaceuticals for Diagnosis Revenue and Market Share by Type (2021-2026)
2.2.8.3 Global Radiopharmaceuticals for Diagnosis Sale Price by Type (2021-2026)
2.3 Radiopharmaceuticals for Diagnosis Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 Radiopharmaceuticals for Diagnosis Sales by Application
2.3.4.1 Global Radiopharmaceuticals for Diagnosis Sale Market Share by Application (2021-2026)
2.3.4.2 Global Radiopharmaceuticals for Diagnosis Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Radiopharmaceuticals for Diagnosis Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Radiopharmaceuticals for Diagnosis Breakdown Data by Company
3.1.1 Global Radiopharmaceuticals for Diagnosis Annual Sales by Company (2021-2026)
3.1.2 Global Radiopharmaceuticals for Diagnosis Sales Market Share by Company (2021-2026)
3.2 Global Radiopharmaceuticals for Diagnosis Annual Revenue by Company (2021-2026)
3.2.1 Global Radiopharmaceuticals for Diagnosis Revenue by Company (2021-2026)
3.2.2 Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Company (2021-2026)
3.3 Global Radiopharmaceuticals for Diagnosis Sale Price by Company
3.4 Key Manufacturers Radiopharmaceuticals for Diagnosis Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Radiopharmaceuticals for Diagnosis Product Location Distribution
3.4.2 Players Radiopharmaceuticals for Diagnosis Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR RADIOPHARMACEUTICALS FOR DIAGNOSIS BY GEOGRAPHIC REGION
4.1 World Historic Radiopharmaceuticals for Diagnosis Market Size by Geographic Region (2021-2026)
4.1.1 Global Radiopharmaceuticals for Diagnosis Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Radiopharmaceuticals for Diagnosis Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Radiopharmaceuticals for Diagnosis Market Size by Country/Region (2021-2026)
4.2.1 Global Radiopharmaceuticals for Diagnosis Annual Sales by Country/Region (2021-2026)
4.2.2 Global Radiopharmaceuticals for Diagnosis Annual Revenue by Country/Region (2021-2026)
4.3 Americas Radiopharmaceuticals for Diagnosis Sales Growth
4.4 APAC Radiopharmaceuticals for Diagnosis Sales Growth
4.5 Europe Radiopharmaceuticals for Diagnosis Sales Growth
4.6 Middle East & Africa Radiopharmaceuticals for Diagnosis Sales Growth
5 AMERICAS
5.1 Americas Radiopharmaceuticals for Diagnosis Sales by Country
5.1.1 Americas Radiopharmaceuticals for Diagnosis Sales by Country (2021-2026)
5.1.2 Americas Radiopharmaceuticals for Diagnosis Revenue by Country (2021-2026)
5.2 Americas Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026)
5.3 Americas Radiopharmaceuticals for Diagnosis Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Radiopharmaceuticals for Diagnosis Sales by Region
6.1.1 APAC Radiopharmaceuticals for Diagnosis Sales by Region (2021-2026)
6.1.2 APAC Radiopharmaceuticals for Diagnosis Revenue by Region (2021-2026)
6.2 APAC Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026)
6.3 APAC Radiopharmaceuticals for Diagnosis Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Radiopharmaceuticals for Diagnosis by Country
7.1.1 Europe Radiopharmaceuticals for Diagnosis Sales by Country (2021-2026)
7.1.2 Europe Radiopharmaceuticals for Diagnosis Revenue by Country (2021-2026)
7.2 Europe Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026)
7.3 Europe Radiopharmaceuticals for Diagnosis Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Radiopharmaceuticals for Diagnosis by Country
8.1.1 Middle East & Africa Radiopharmaceuticals for Diagnosis Sales by Country (2021-2026)
8.1.2 Middle East & Africa Radiopharmaceuticals for Diagnosis Revenue by Country (2021-2026)
8.2 Middle East & Africa Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026)
8.3 Middle East & Africa Radiopharmaceuticals for Diagnosis Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Radiopharmaceuticals for Diagnosis
10.3 Manufacturing Process Analysis of Radiopharmaceuticals for Diagnosis
10.4 Industry Chain Structure of Radiopharmaceuticals for Diagnosis
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Radiopharmaceuticals for Diagnosis Distributors
11.3 Radiopharmaceuticals for Diagnosis Customer
12 WORLD FORECAST REVIEW FOR RADIOPHARMACEUTICALS FOR DIAGNOSIS BY GEOGRAPHIC REGION
12.1 Global Radiopharmaceuticals for Diagnosis Market Size Forecast by Region
12.1.1 Global Radiopharmaceuticals for Diagnosis Forecast by Region (2027-2032)
12.1.2 Global Radiopharmaceuticals for Diagnosis Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Radiopharmaceuticals for Diagnosis Forecast by Type (2027-2032)
12.7 Global Radiopharmaceuticals for Diagnosis Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Atom High-tech Co., Ltd.
13.1.1 Atom High-tech Co., Ltd. Company Information
13.1.2 Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.1.3 Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Atom High-tech Co., Ltd. Main Business Overview
13.1.5 Atom High-tech Co., Ltd. Latest Developments
13.2 Shanghai Xinke Pharmaceutical Co., Ltd.
13.2.1 Shanghai Xinke Pharmaceutical Co., Ltd. Company Information
13.2.2 Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.2.3 Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Shanghai Xinke Pharmaceutical Co., Ltd. Main Business Overview
13.2.5 Shanghai Xinke Pharmaceutical Co., Ltd. Latest Developments
13.3 Guangdong Xi'ai Pharmaceutical Co., Ltd.
13.3.1 Guangdong Xi'ai Pharmaceutical Co., Ltd. Company Information
13.3.2 Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.3.3 Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Guangdong Xi'ai Pharmaceutical Co., Ltd. Main Business Overview
13.3.5 Guangdong Xi'ai Pharmaceutical Co., Ltd. Latest Developments
13.4 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory
13.4.1 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Company Information
13.4.2 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.4.3 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Main Business Overview
13.4.5 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Latest Developments
13.5 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd.
13.5.1 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Company Information
13.5.2 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.5.3 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Main Business Overview
13.5.5 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Latest Developments
13.6 Chengdu Yunke Pharmaceutical Co., Ltd.
13.6.1 Chengdu Yunke Pharmaceutical Co., Ltd. Company Information
13.6.2 Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.6.3 Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Chengdu Yunke Pharmaceutical Co., Ltd. Main Business Overview
13.6.5 Chengdu Yunke Pharmaceutical Co., Ltd. Latest Developments
13.7 Shanghai Atom Kexing Pharmaceutical Co., Ltd.
13.7.1 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Company Information
13.7.2 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.7.3 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Main Business Overview
13.7.5 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Latest Developments
13.8 Shenzhen Larven Bioengineering Technology Co., Ltd.
13.8.1 Shenzhen Larven Bioengineering Technology Co., Ltd. Company Information
13.8.2 Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.8.3 Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Shenzhen Larven Bioengineering Technology Co., Ltd. Main Business Overview
13.8.5 Shenzhen Larven Bioengineering Technology Co., Ltd. Latest Developments
13.9 Ningbo Jun'an Pharmaceutical Technology Co., Ltd.
13.9.1 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Company Information
13.9.2 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.9.3 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Main Business Overview
13.9.5 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Latest Developments
13.10 Beijing Zhibo High-tech Biotechnology Co., Ltd.
13.10.1 Beijing Zhibo High-tech Biotechnology Co., Ltd. Company Information
13.10.2 Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.10.3 Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Beijing Zhibo High-tech Biotechnology Co., Ltd. Main Business Overview
13.10.5 Beijing Zhibo High-tech Biotechnology Co., Ltd. Latest Developments
13.11 Tianjin Said Biopharmaceutical Co., Ltd.
13.11.1 Tianjin Said Biopharmaceutical Co., Ltd. Company Information
13.11.2 Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.11.3 Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Tianjin Said Biopharmaceutical Co., Ltd. Main Business Overview
13.11.5 Tianjin Said Biopharmaceutical Co., Ltd. Latest Developments
13.12 Chengdu Zhonghe Gaotong Isotope Co., Ltd.
13.12.1 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Company Information
13.12.2 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.12.3 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Main Business Overview
13.12.5 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Latest Developments
13.13 Chengdu Xinke Pharmaceutical Co., Ltd.
13.13.1 Chengdu Xinke Pharmaceutical Co., Ltd. Company Information
13.13.2 Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.13.3 Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Chengdu Xinke Pharmaceutical Co., Ltd. Main Business Overview
13.13.5 Chengdu Xinke Pharmaceutical Co., Ltd. Latest Developments
13.14 Jubilant Radiopharma
13.14.1 Jubilant Radiopharma Company Information
13.14.2 Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.14.3 Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Jubilant Radiopharma Main Business Overview
13.14.5 Jubilant Radiopharma Latest Developments
13.15 PDRadiopharma Inc.
13.15.1 PDRadiopharma Inc. Company Information
13.15.2 PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.15.3 PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 PDRadiopharma Inc. Main Business Overview
13.15.5 PDRadiopharma Inc. Latest Developments
13.16 GE Healthcare Ltd
13.16.1 GE Healthcare Ltd Company Information
13.16.2 GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.16.3 GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 GE Healthcare Ltd Main Business Overview
13.16.5 GE Healthcare Ltd Latest Developments
13.17 DOE IP
13.17.1 DOE IP Company Information
13.17.2 DOE IP Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.17.3 DOE IP Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 DOE IP Main Business Overview
13.17.5 DOE IP Latest Developments
13.18 RadioMedix, Inc.
13.18.1 RadioMedix, Inc. Company Information
13.18.2 RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.18.3 RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 RadioMedix, Inc. Main Business Overview
13.18.5 RadioMedix, Inc. Latest Developments
13.19 Lantheus
13.19.1 Lantheus Company Information
13.19.2 Lantheus Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
13.19.3 Lantheus Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Lantheus Main Business Overview
13.19.5 Lantheus Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Radiopharmaceuticals for Diagnosis Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Radiopharmaceuticals for Diagnosis Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Technetium 99mTc Dithiodithiocarbamate
Table 4. Major Players of Technetium 99mTc Polymerized Albumin
Table 5. Major Players of Technetium 99mTc Pentetate
Table 6. Major Players of Strontium 89Sr Chloride
Table 7. Major Players of Iodine 125I Sealed Seed Source
Table 8. Major Players of Sodium Iodide 131I
Table 9. Major Players of Other
Table 10. Global Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026) & (K Units)
Table 11. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Type (2021-2026)
Table 12. Global Radiopharmaceuticals for Diagnosis Revenue by Type (2021-2026) & ($ million)
Table 13. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Type (2021-2026)
Table 14. Global Radiopharmaceuticals for Diagnosis Sale Price by Type (2021-2026) & (US$/Unit)
Table 15. Global Radiopharmaceuticals for Diagnosis Sale by Application (2021-2026) & (K Units)
Table 16. Global Radiopharmaceuticals for Diagnosis Sale Market Share by Application (2021-2026)
Table 17. Global Radiopharmaceuticals for Diagnosis Revenue by Application (2021-2026) & ($ million)
Table 18. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Application (2021-2026)
Table 19. Global Radiopharmaceuticals for Diagnosis Sale Price by Application (2021-2026) & (US$/Unit)
Table 20. Global Radiopharmaceuticals for Diagnosis Sales by Company (2021-2026) & (K Units)
Table 21. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Company (2021-2026)
Table 22. Global Radiopharmaceuticals for Diagnosis Revenue by Company (2021-2026) & ($ millions)
Table 23. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Company (2021-2026)
Table 24. Global Radiopharmaceuticals for Diagnosis Sale Price by Company (2021-2026) & (US$/Unit)
Table 25. Key Manufacturers Radiopharmaceuticals for Diagnosis Producing Area Distribution and Sales Area
Table 26. Players Radiopharmaceuticals for Diagnosis Products Offered
Table 27. Radiopharmaceuticals for Diagnosis Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 28. New Products and Potential Entrants
Table 29. Market M&A Activity & Strategy
Table 30. Global Radiopharmaceuticals for Diagnosis Sales by Geographic Region (2021-2026) & (K Units)
Table 31. Global Radiopharmaceuticals for Diagnosis Sales Market Share Geographic Region (2021-2026)
Table 32. Global Radiopharmaceuticals for Diagnosis Revenue by Geographic Region (2021-2026) & ($ millions)
Table 33. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Geographic Region (2021-2026)
Table 34. Global Radiopharmaceuticals for Diagnosis Sales by Country/Region (2021-2026) & (K Units)
Table 35. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Country/Region (2021-2026)
Table 36. Global Radiopharmaceuticals for Diagnosis Revenue by Country/Region (2021-2026) & ($ millions)
Table 37. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Country/Region (2021-2026)
Table 38. Americas Radiopharmaceuticals for Diagnosis Sales by Country (2021-2026) & (K Units)
Table 39. Americas Radiopharmaceuticals for Diagnosis Sales Market Share by Country (2021-2026)
Table 40. Americas Radiopharmaceuticals for Diagnosis Revenue by Country (2021-2026) & ($ millions)
Table 41. Americas Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026) & (K Units)
Table 42. Americas Radiopharmaceuticals for Diagnosis Sales by Application (2021-2026) & (K Units)
Table 43. APAC Radiopharmaceuticals for Diagnosis Sales by Region (2021-2026) & (K Units)
Table 44. APAC Radiopharmaceuticals for Diagnosis Sales Market Share by Region (2021-2026)
Table 45. APAC Radiopharmaceuticals for Diagnosis Revenue by Region (2021-2026) & ($ millions)
Table 46. APAC Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026) & (K Units)
Table 47. APAC Radiopharmaceuticals for Diagnosis Sales by Application (2021-2026) & (K Units)
Table 48. Europe Radiopharmaceuticals for Diagnosis Sales by Country (2021-2026) & (K Units)
Table 49. Europe Radiopharmaceuticals for Diagnosis Revenue by Country (2021-2026) & ($ millions)
Table 50. Europe Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026) & (K Units)
Table 51. Europe Radiopharmaceuticals for Diagnosis Sales by Application (2021-2026) & (K Units)
Table 52. Middle East & Africa Radiopharmaceuticals for Diagnosis Sales by Country (2021-2026) & (K Units)
Table 53. Middle East & Africa Radiopharmaceuticals for Diagnosis Revenue Market Share by Country (2021-2026)
Table 54. Middle East & Africa Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026) & (K Units)
Table 55. Middle East & Africa Radiopharmaceuticals for Diagnosis Sales by Application (2021-2026) & (K Units)
Table 56. Key Market Drivers & Growth Opportunities of Radiopharmaceuticals for Diagnosis
Table 57. Key Market Challenges & Risks of Radiopharmaceuticals for Diagnosis
Table 58. Key Industry Trends of Radiopharmaceuticals for Diagnosis
Table 59. Radiopharmaceuticals for Diagnosis Raw Material
Table 60. Key Suppliers of Raw Materials
Table 61. Radiopharmaceuticals for Diagnosis Distributors List
Table 62. Radiopharmaceuticals for Diagnosis Customer List
Table 63. Global Radiopharmaceuticals for Diagnosis Sales Forecast by Region (2027-2032) & (K Units)
Table 64. Global Radiopharmaceuticals for Diagnosis Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Americas Radiopharmaceuticals for Diagnosis Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Americas Radiopharmaceuticals for Diagnosis Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. APAC Radiopharmaceuticals for Diagnosis Sales Forecast by Region (2027-2032) & (K Units)
Table 68. APAC Radiopharmaceuticals for Diagnosis Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 69. Europe Radiopharmaceuticals for Diagnosis Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Europe Radiopharmaceuticals for Diagnosis Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. Middle East & Africa Radiopharmaceuticals for Diagnosis Sales Forecast by Country (2027-2032) & (K Units)
Table 72. Middle East & Africa Radiopharmaceuticals for Diagnosis Revenue Forecast by Country (2027-2032) & ($ millions)
Table 73. Global Radiopharmaceuticals for Diagnosis Sales Forecast by Type (2027-2032) & (K Units)
Table 74. Global Radiopharmaceuticals for Diagnosis Revenue Forecast by Type (2027-2032) & ($ millions)
Table 75. Global Radiopharmaceuticals for Diagnosis Sales Forecast by Application (2027-2032) & (K Units)
Table 76. Global Radiopharmaceuticals for Diagnosis Revenue Forecast by Application (2027-2032) & ($ millions)
Table 77. Atom High-tech Co., Ltd. Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 78. Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 79. Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Atom High-tech Co., Ltd. Main Business
Table 81. Atom High-tech Co., Ltd. Latest Developments
Table 82. Shanghai Xinke Pharmaceutical Co., Ltd. Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 83. Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 84. Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Shanghai Xinke Pharmaceutical Co., Ltd. Main Business
Table 86. Shanghai Xinke Pharmaceutical Co., Ltd. Latest Developments
Table 87. Guangdong Xi'ai Pharmaceutical Co., Ltd. Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 88. Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 89. Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Guangdong Xi'ai Pharmaceutical Co., Ltd. Main Business
Table 91. Guangdong Xi'ai Pharmaceutical Co., Ltd. Latest Developments
Table 92. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 93. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 94. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Main Business
Table 96. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Latest Developments
Table 97. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 98. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 99. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Main Business
Table 101. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Latest Developments
Table 102. Chengdu Yunke Pharmaceutical Co., Ltd. Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 103. Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 104. Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Chengdu Yunke Pharmaceutical Co., Ltd. Main Business
Table 106. Chengdu Yunke Pharmaceutical Co., Ltd. Latest Developments
Table 107. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 108. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 109. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Main Business
Table 111. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Latest Developments
Table 112. Shenzhen Larven Bioengineering Technology Co., Ltd. Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 113. Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 114. Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Shenzhen Larven Bioengineering Technology Co., Ltd. Main Business
Table 116. Shenzhen Larven Bioengineering Technology Co., Ltd. Latest Developments
Table 117. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 118. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 119. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Main Business
Table 121. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Latest Developments
Table 122. Beijing Zhibo High-tech Biotechnology Co., Ltd. Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 123. Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 124. Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Beijing Zhibo High-tech Biotechnology Co., Ltd. Main Business
Table 126. Beijing Zhibo High-tech Biotechnology Co., Ltd. Latest Developments
Table 127. Tianjin Said Biopharmaceutical Co., Ltd. Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 128. Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 129. Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Tianjin Said Biopharmaceutical Co., Ltd. Main Business
Table 131. Tianjin Said Biopharmaceutical Co., Ltd. Latest Developments
Table 132. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 133. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 134. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Main Business
Table 136. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Latest Developments
Table 137. Chengdu Xinke Pharmaceutical Co., Ltd. Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 138. Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 139. Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Chengdu Xinke Pharmaceutical Co., Ltd. Main Business
Table 141. Chengdu Xinke Pharmaceutical Co., Ltd. Latest Developments
Table 142. Jubilant Radiopharma Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 143. Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 144. Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Jubilant Radiopharma Main Business
Table 146. Jubilant Radiopharma Latest Developments
Table 147. PDRadiopharma Inc. Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 148. PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 149. PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. PDRadiopharma Inc. Main Business
Table 151. PDRadiopharma Inc. Latest Developments
Table 152. GE Healthcare Ltd Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 153. GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 154. GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. GE Healthcare Ltd Main Business
Table 156. GE Healthcare Ltd Latest Developments
Table 157. DOE IP Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 158. DOE IP Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 159. DOE IP Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 160. DOE IP Main Business
Table 161. DOE IP Latest Developments
Table 162. RadioMedix, Inc. Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 163. RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 164. RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 165. RadioMedix, Inc. Main Business
Table 166. RadioMedix, Inc. Latest Developments
Table 167. Lantheus Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 168. Lantheus Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 169. Lantheus Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 170. Lantheus Main Business
Table 171. Lantheus Latest Developments
Table 1. Radiopharmaceuticals for Diagnosis Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Radiopharmaceuticals for Diagnosis Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Technetium 99mTc Dithiodithiocarbamate
Table 4. Major Players of Technetium 99mTc Polymerized Albumin
Table 5. Major Players of Technetium 99mTc Pentetate
Table 6. Major Players of Strontium 89Sr Chloride
Table 7. Major Players of Iodine 125I Sealed Seed Source
Table 8. Major Players of Sodium Iodide 131I
Table 9. Major Players of Other
Table 10. Global Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026) & (K Units)
Table 11. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Type (2021-2026)
Table 12. Global Radiopharmaceuticals for Diagnosis Revenue by Type (2021-2026) & ($ million)
Table 13. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Type (2021-2026)
Table 14. Global Radiopharmaceuticals for Diagnosis Sale Price by Type (2021-2026) & (US$/Unit)
Table 15. Global Radiopharmaceuticals for Diagnosis Sale by Application (2021-2026) & (K Units)
Table 16. Global Radiopharmaceuticals for Diagnosis Sale Market Share by Application (2021-2026)
Table 17. Global Radiopharmaceuticals for Diagnosis Revenue by Application (2021-2026) & ($ million)
Table 18. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Application (2021-2026)
Table 19. Global Radiopharmaceuticals for Diagnosis Sale Price by Application (2021-2026) & (US$/Unit)
Table 20. Global Radiopharmaceuticals for Diagnosis Sales by Company (2021-2026) & (K Units)
Table 21. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Company (2021-2026)
Table 22. Global Radiopharmaceuticals for Diagnosis Revenue by Company (2021-2026) & ($ millions)
Table 23. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Company (2021-2026)
Table 24. Global Radiopharmaceuticals for Diagnosis Sale Price by Company (2021-2026) & (US$/Unit)
Table 25. Key Manufacturers Radiopharmaceuticals for Diagnosis Producing Area Distribution and Sales Area
Table 26. Players Radiopharmaceuticals for Diagnosis Products Offered
Table 27. Radiopharmaceuticals for Diagnosis Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 28. New Products and Potential Entrants
Table 29. Market M&A Activity & Strategy
Table 30. Global Radiopharmaceuticals for Diagnosis Sales by Geographic Region (2021-2026) & (K Units)
Table 31. Global Radiopharmaceuticals for Diagnosis Sales Market Share Geographic Region (2021-2026)
Table 32. Global Radiopharmaceuticals for Diagnosis Revenue by Geographic Region (2021-2026) & ($ millions)
Table 33. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Geographic Region (2021-2026)
Table 34. Global Radiopharmaceuticals for Diagnosis Sales by Country/Region (2021-2026) & (K Units)
Table 35. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Country/Region (2021-2026)
Table 36. Global Radiopharmaceuticals for Diagnosis Revenue by Country/Region (2021-2026) & ($ millions)
Table 37. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Country/Region (2021-2026)
Table 38. Americas Radiopharmaceuticals for Diagnosis Sales by Country (2021-2026) & (K Units)
Table 39. Americas Radiopharmaceuticals for Diagnosis Sales Market Share by Country (2021-2026)
Table 40. Americas Radiopharmaceuticals for Diagnosis Revenue by Country (2021-2026) & ($ millions)
Table 41. Americas Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026) & (K Units)
Table 42. Americas Radiopharmaceuticals for Diagnosis Sales by Application (2021-2026) & (K Units)
Table 43. APAC Radiopharmaceuticals for Diagnosis Sales by Region (2021-2026) & (K Units)
Table 44. APAC Radiopharmaceuticals for Diagnosis Sales Market Share by Region (2021-2026)
Table 45. APAC Radiopharmaceuticals for Diagnosis Revenue by Region (2021-2026) & ($ millions)
Table 46. APAC Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026) & (K Units)
Table 47. APAC Radiopharmaceuticals for Diagnosis Sales by Application (2021-2026) & (K Units)
Table 48. Europe Radiopharmaceuticals for Diagnosis Sales by Country (2021-2026) & (K Units)
Table 49. Europe Radiopharmaceuticals for Diagnosis Revenue by Country (2021-2026) & ($ millions)
Table 50. Europe Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026) & (K Units)
Table 51. Europe Radiopharmaceuticals for Diagnosis Sales by Application (2021-2026) & (K Units)
Table 52. Middle East & Africa Radiopharmaceuticals for Diagnosis Sales by Country (2021-2026) & (K Units)
Table 53. Middle East & Africa Radiopharmaceuticals for Diagnosis Revenue Market Share by Country (2021-2026)
Table 54. Middle East & Africa Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026) & (K Units)
Table 55. Middle East & Africa Radiopharmaceuticals for Diagnosis Sales by Application (2021-2026) & (K Units)
Table 56. Key Market Drivers & Growth Opportunities of Radiopharmaceuticals for Diagnosis
Table 57. Key Market Challenges & Risks of Radiopharmaceuticals for Diagnosis
Table 58. Key Industry Trends of Radiopharmaceuticals for Diagnosis
Table 59. Radiopharmaceuticals for Diagnosis Raw Material
Table 60. Key Suppliers of Raw Materials
Table 61. Radiopharmaceuticals for Diagnosis Distributors List
Table 62. Radiopharmaceuticals for Diagnosis Customer List
Table 63. Global Radiopharmaceuticals for Diagnosis Sales Forecast by Region (2027-2032) & (K Units)
Table 64. Global Radiopharmaceuticals for Diagnosis Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Americas Radiopharmaceuticals for Diagnosis Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Americas Radiopharmaceuticals for Diagnosis Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. APAC Radiopharmaceuticals for Diagnosis Sales Forecast by Region (2027-2032) & (K Units)
Table 68. APAC Radiopharmaceuticals for Diagnosis Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 69. Europe Radiopharmaceuticals for Diagnosis Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Europe Radiopharmaceuticals for Diagnosis Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. Middle East & Africa Radiopharmaceuticals for Diagnosis Sales Forecast by Country (2027-2032) & (K Units)
Table 72. Middle East & Africa Radiopharmaceuticals for Diagnosis Revenue Forecast by Country (2027-2032) & ($ millions)
Table 73. Global Radiopharmaceuticals for Diagnosis Sales Forecast by Type (2027-2032) & (K Units)
Table 74. Global Radiopharmaceuticals for Diagnosis Revenue Forecast by Type (2027-2032) & ($ millions)
Table 75. Global Radiopharmaceuticals for Diagnosis Sales Forecast by Application (2027-2032) & (K Units)
Table 76. Global Radiopharmaceuticals for Diagnosis Revenue Forecast by Application (2027-2032) & ($ millions)
Table 77. Atom High-tech Co., Ltd. Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 78. Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 79. Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Atom High-tech Co., Ltd. Main Business
Table 81. Atom High-tech Co., Ltd. Latest Developments
Table 82. Shanghai Xinke Pharmaceutical Co., Ltd. Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 83. Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 84. Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Shanghai Xinke Pharmaceutical Co., Ltd. Main Business
Table 86. Shanghai Xinke Pharmaceutical Co., Ltd. Latest Developments
Table 87. Guangdong Xi'ai Pharmaceutical Co., Ltd. Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 88. Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 89. Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Guangdong Xi'ai Pharmaceutical Co., Ltd. Main Business
Table 91. Guangdong Xi'ai Pharmaceutical Co., Ltd. Latest Developments
Table 92. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 93. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 94. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Main Business
Table 96. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Latest Developments
Table 97. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 98. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 99. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Main Business
Table 101. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Latest Developments
Table 102. Chengdu Yunke Pharmaceutical Co., Ltd. Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 103. Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 104. Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Chengdu Yunke Pharmaceutical Co., Ltd. Main Business
Table 106. Chengdu Yunke Pharmaceutical Co., Ltd. Latest Developments
Table 107. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 108. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 109. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Main Business
Table 111. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Latest Developments
Table 112. Shenzhen Larven Bioengineering Technology Co., Ltd. Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 113. Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 114. Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Shenzhen Larven Bioengineering Technology Co., Ltd. Main Business
Table 116. Shenzhen Larven Bioengineering Technology Co., Ltd. Latest Developments
Table 117. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 118. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 119. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Main Business
Table 121. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Latest Developments
Table 122. Beijing Zhibo High-tech Biotechnology Co., Ltd. Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 123. Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 124. Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Beijing Zhibo High-tech Biotechnology Co., Ltd. Main Business
Table 126. Beijing Zhibo High-tech Biotechnology Co., Ltd. Latest Developments
Table 127. Tianjin Said Biopharmaceutical Co., Ltd. Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 128. Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 129. Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Tianjin Said Biopharmaceutical Co., Ltd. Main Business
Table 131. Tianjin Said Biopharmaceutical Co., Ltd. Latest Developments
Table 132. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 133. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 134. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Main Business
Table 136. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Latest Developments
Table 137. Chengdu Xinke Pharmaceutical Co., Ltd. Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 138. Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 139. Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Chengdu Xinke Pharmaceutical Co., Ltd. Main Business
Table 141. Chengdu Xinke Pharmaceutical Co., Ltd. Latest Developments
Table 142. Jubilant Radiopharma Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 143. Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 144. Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Jubilant Radiopharma Main Business
Table 146. Jubilant Radiopharma Latest Developments
Table 147. PDRadiopharma Inc. Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 148. PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 149. PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. PDRadiopharma Inc. Main Business
Table 151. PDRadiopharma Inc. Latest Developments
Table 152. GE Healthcare Ltd Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 153. GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 154. GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. GE Healthcare Ltd Main Business
Table 156. GE Healthcare Ltd Latest Developments
Table 157. DOE IP Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 158. DOE IP Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 159. DOE IP Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 160. DOE IP Main Business
Table 161. DOE IP Latest Developments
Table 162. RadioMedix, Inc. Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 163. RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 164. RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 165. RadioMedix, Inc. Main Business
Table 166. RadioMedix, Inc. Latest Developments
Table 167. Lantheus Basic Information, Radiopharmaceuticals for Diagnosis Manufacturing Base, Sales Area and Its Competitors
Table 168. Lantheus Radiopharmaceuticals for Diagnosis Product Portfolios and Specifications
Table 169. Lantheus Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 170. Lantheus Main Business
Table 171. Lantheus Latest Developments
LIST OF FIGURES
Figure 1. Picture of Radiopharmaceuticals for Diagnosis
Figure 2. Radiopharmaceuticals for Diagnosis Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Radiopharmaceuticals for Diagnosis Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Radiopharmaceuticals for Diagnosis Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Radiopharmaceuticals for Diagnosis Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Radiopharmaceuticals for Diagnosis Sales Market Share by Country/Region (2025)
Figure 10. Radiopharmaceuticals for Diagnosis Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Technetium 99mTc Dithiodithiocarbamate
Figure 12. Product Picture of Technetium 99mTc Polymerized Albumin
Figure 13. Product Picture of Technetium 99mTc Pentetate
Figure 14. Product Picture of Strontium 89Sr Chloride
Figure 15. Product Picture of Iodine 125I Sealed Seed Source
Figure 16. Product Picture of Sodium Iodide 131I
Figure 17. Product Picture of Other
Figure 18. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Type in 2026
Figure 19. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Type (2021-2026)
Figure 20. Radiopharmaceuticals for Diagnosis Consumed in Hospital
Figure 21. Global Radiopharmaceuticals for Diagnosis Market: Hospital (2021-2026) & (K Units)
Figure 22. Radiopharmaceuticals for Diagnosis Consumed in Clinic
Figure 23. Global Radiopharmaceuticals for Diagnosis Market: Clinic (2021-2026) & (K Units)
Figure 24. Radiopharmaceuticals for Diagnosis Consumed in Other
Figure 25. Global Radiopharmaceuticals for Diagnosis Market: Other (2021-2026) & (K Units)
Figure 26. Global Radiopharmaceuticals for Diagnosis Sale Market Share by Application (2025)
Figure 27. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Application in 2026
Figure 28. Radiopharmaceuticals for Diagnosis Sales by Company in 2026 (K Units)
Figure 29. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Company in 2026
Figure 30. Radiopharmaceuticals for Diagnosis Revenue by Company in 2026 ($ millions)
Figure 31. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Company in 2026
Figure 32. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Geographic Region (2021-2026)
Figure 33. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Geographic Region in 2026
Figure 34. Americas Radiopharmaceuticals for Diagnosis Sales 2021-2026 (K Units)
Figure 35. Americas Radiopharmaceuticals for Diagnosis Revenue 2021-2026 ($ millions)
Figure 36. APAC Radiopharmaceuticals for Diagnosis Sales 2021-2026 (K Units)
Figure 37. APAC Radiopharmaceuticals for Diagnosis Revenue 2021-2026 ($ millions)
Figure 38. Europe Radiopharmaceuticals for Diagnosis Sales 2021-2026 (K Units)
Figure 39. Europe Radiopharmaceuticals for Diagnosis Revenue 2021-2026 ($ millions)
Figure 40. Middle East & Africa Radiopharmaceuticals for Diagnosis Sales 2021-2026 (K Units)
Figure 41. Middle East & Africa Radiopharmaceuticals for Diagnosis Revenue 2021-2026 ($ millions)
Figure 42. Americas Radiopharmaceuticals for Diagnosis Sales Market Share by Country in 2026
Figure 43. Americas Radiopharmaceuticals for Diagnosis Revenue Market Share by Country (2021-2026)
Figure 44. Americas Radiopharmaceuticals for Diagnosis Sales Market Share by Type (2021-2026)
Figure 45. Americas Radiopharmaceuticals for Diagnosis Sales Market Share by Application (2021-2026)
Figure 46. United States Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 47. Canada Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 48. Mexico Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 49. Brazil Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 50. APAC Radiopharmaceuticals for Diagnosis Sales Market Share by Region in 2026
Figure 51. APAC Radiopharmaceuticals for Diagnosis Revenue Market Share by Region (2021-2026)
Figure 52. APAC Radiopharmaceuticals for Diagnosis Sales Market Share by Type (2021-2026)
Figure 53. APAC Radiopharmaceuticals for Diagnosis Sales Market Share by Application (2021-2026)
Figure 54. China Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 55. Japan Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 56. South Korea Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 57. Southeast Asia Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 58. India Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 59. Australia Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 60. China Taiwan Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 61. Europe Radiopharmaceuticals for Diagnosis Sales Market Share by Country in 2026
Figure 62. Europe Radiopharmaceuticals for Diagnosis Revenue Market Share by Country (2021-2026)
Figure 63. Europe Radiopharmaceuticals for Diagnosis Sales Market Share by Type (2021-2026)
Figure 64. Europe Radiopharmaceuticals for Diagnosis Sales Market Share by Application (2021-2026)
Figure 65. Germany Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 66. France Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 67. UK Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 68. Italy Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 69. Russia Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 70. Middle East & Africa Radiopharmaceuticals for Diagnosis Sales Market Share by Country (2021-2026)
Figure 71. Middle East & Africa Radiopharmaceuticals for Diagnosis Sales Market Share by Type (2021-2026)
Figure 72. Middle East & Africa Radiopharmaceuticals for Diagnosis Sales Market Share by Application (2021-2026)
Figure 73. Egypt Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 74. South Africa Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 75. Israel Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 76. Turkey Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 77. GCC Countries Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Radiopharmaceuticals for Diagnosis in 2026
Figure 79. Manufacturing Process Analysis of Radiopharmaceuticals for Diagnosis
Figure 80. Industry Chain Structure of Radiopharmaceuticals for Diagnosis
Figure 81. Channels of Distribution
Figure 82. Global Radiopharmaceuticals for Diagnosis Sales Market Forecast by Region (2027-2032)
Figure 83. Global Radiopharmaceuticals for Diagnosis Revenue Market Share Forecast by Region (2027-2032)
Figure 84. Global Radiopharmaceuticals for Diagnosis Sales Market Share Forecast by Type (2027-2032)
Figure 85. Global Radiopharmaceuticals for Diagnosis Revenue Market Share Forecast by Type (2027-2032)
Figure 86. Global Radiopharmaceuticals for Diagnosis Sales Market Share Forecast by Application (2027-2032)
Figure 87. Global Radiopharmaceuticals for Diagnosis Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Radiopharmaceuticals for Diagnosis
Figure 2. Radiopharmaceuticals for Diagnosis Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Radiopharmaceuticals for Diagnosis Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Radiopharmaceuticals for Diagnosis Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Radiopharmaceuticals for Diagnosis Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Radiopharmaceuticals for Diagnosis Sales Market Share by Country/Region (2025)
Figure 10. Radiopharmaceuticals for Diagnosis Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Technetium 99mTc Dithiodithiocarbamate
Figure 12. Product Picture of Technetium 99mTc Polymerized Albumin
Figure 13. Product Picture of Technetium 99mTc Pentetate
Figure 14. Product Picture of Strontium 89Sr Chloride
Figure 15. Product Picture of Iodine 125I Sealed Seed Source
Figure 16. Product Picture of Sodium Iodide 131I
Figure 17. Product Picture of Other
Figure 18. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Type in 2026
Figure 19. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Type (2021-2026)
Figure 20. Radiopharmaceuticals for Diagnosis Consumed in Hospital
Figure 21. Global Radiopharmaceuticals for Diagnosis Market: Hospital (2021-2026) & (K Units)
Figure 22. Radiopharmaceuticals for Diagnosis Consumed in Clinic
Figure 23. Global Radiopharmaceuticals for Diagnosis Market: Clinic (2021-2026) & (K Units)
Figure 24. Radiopharmaceuticals for Diagnosis Consumed in Other
Figure 25. Global Radiopharmaceuticals for Diagnosis Market: Other (2021-2026) & (K Units)
Figure 26. Global Radiopharmaceuticals for Diagnosis Sale Market Share by Application (2025)
Figure 27. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Application in 2026
Figure 28. Radiopharmaceuticals for Diagnosis Sales by Company in 2026 (K Units)
Figure 29. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Company in 2026
Figure 30. Radiopharmaceuticals for Diagnosis Revenue by Company in 2026 ($ millions)
Figure 31. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Company in 2026
Figure 32. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Geographic Region (2021-2026)
Figure 33. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Geographic Region in 2026
Figure 34. Americas Radiopharmaceuticals for Diagnosis Sales 2021-2026 (K Units)
Figure 35. Americas Radiopharmaceuticals for Diagnosis Revenue 2021-2026 ($ millions)
Figure 36. APAC Radiopharmaceuticals for Diagnosis Sales 2021-2026 (K Units)
Figure 37. APAC Radiopharmaceuticals for Diagnosis Revenue 2021-2026 ($ millions)
Figure 38. Europe Radiopharmaceuticals for Diagnosis Sales 2021-2026 (K Units)
Figure 39. Europe Radiopharmaceuticals for Diagnosis Revenue 2021-2026 ($ millions)
Figure 40. Middle East & Africa Radiopharmaceuticals for Diagnosis Sales 2021-2026 (K Units)
Figure 41. Middle East & Africa Radiopharmaceuticals for Diagnosis Revenue 2021-2026 ($ millions)
Figure 42. Americas Radiopharmaceuticals for Diagnosis Sales Market Share by Country in 2026
Figure 43. Americas Radiopharmaceuticals for Diagnosis Revenue Market Share by Country (2021-2026)
Figure 44. Americas Radiopharmaceuticals for Diagnosis Sales Market Share by Type (2021-2026)
Figure 45. Americas Radiopharmaceuticals for Diagnosis Sales Market Share by Application (2021-2026)
Figure 46. United States Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 47. Canada Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 48. Mexico Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 49. Brazil Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 50. APAC Radiopharmaceuticals for Diagnosis Sales Market Share by Region in 2026
Figure 51. APAC Radiopharmaceuticals for Diagnosis Revenue Market Share by Region (2021-2026)
Figure 52. APAC Radiopharmaceuticals for Diagnosis Sales Market Share by Type (2021-2026)
Figure 53. APAC Radiopharmaceuticals for Diagnosis Sales Market Share by Application (2021-2026)
Figure 54. China Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 55. Japan Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 56. South Korea Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 57. Southeast Asia Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 58. India Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 59. Australia Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 60. China Taiwan Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 61. Europe Radiopharmaceuticals for Diagnosis Sales Market Share by Country in 2026
Figure 62. Europe Radiopharmaceuticals for Diagnosis Revenue Market Share by Country (2021-2026)
Figure 63. Europe Radiopharmaceuticals for Diagnosis Sales Market Share by Type (2021-2026)
Figure 64. Europe Radiopharmaceuticals for Diagnosis Sales Market Share by Application (2021-2026)
Figure 65. Germany Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 66. France Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 67. UK Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 68. Italy Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 69. Russia Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 70. Middle East & Africa Radiopharmaceuticals for Diagnosis Sales Market Share by Country (2021-2026)
Figure 71. Middle East & Africa Radiopharmaceuticals for Diagnosis Sales Market Share by Type (2021-2026)
Figure 72. Middle East & Africa Radiopharmaceuticals for Diagnosis Sales Market Share by Application (2021-2026)
Figure 73. Egypt Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 74. South Africa Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 75. Israel Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 76. Turkey Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 77. GCC Countries Radiopharmaceuticals for Diagnosis Revenue Growth 2021-2026 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Radiopharmaceuticals for Diagnosis in 2026
Figure 79. Manufacturing Process Analysis of Radiopharmaceuticals for Diagnosis
Figure 80. Industry Chain Structure of Radiopharmaceuticals for Diagnosis
Figure 81. Channels of Distribution
Figure 82. Global Radiopharmaceuticals for Diagnosis Sales Market Forecast by Region (2027-2032)
Figure 83. Global Radiopharmaceuticals for Diagnosis Revenue Market Share Forecast by Region (2027-2032)
Figure 84. Global Radiopharmaceuticals for Diagnosis Sales Market Share Forecast by Type (2027-2032)
Figure 85. Global Radiopharmaceuticals for Diagnosis Revenue Market Share Forecast by Type (2027-2032)
Figure 86. Global Radiopharmaceuticals for Diagnosis Sales Market Share Forecast by Application (2027-2032)
Figure 87. Global Radiopharmaceuticals for Diagnosis Revenue Market Share Forecast by Application (2027-2032)
